The Open AIDS Journal

ISSN: ― Volume ,

Achieving a Dream: Meeting Policy Goals Related to Improving Drug Access

David Zakus*, 1, 2, 3, Jillian Clare Kohler4, Venera Zakriova1, 2, Aaron Yarmoshuk2, 5
1 Centre for International Health, Canada
2 Dalla Lana School of Public Health, Canada
3 Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Canada
4 Faculty of Pharmacy, University of Toronto, Canada
5 HIV/AIDS Africa Initiative, Centre for International Health, Canada


International experts recognize that significant inequities exist in the accessibility of life-saving medicines among poor and vulnerable populations, especially in developing countries. This article highlights that drug access even for relatively cheap medicines is out of reach for the vast numbers of global poor. This badly affects people living with HIV/AIDS who face serious obstacles in accessing ARVs. The same concerns are attributed to neglected diseases. Despite international meetings, promises from the pharmaceutical industry and a lot of media attention little has changed in the past 20 years. The accessibility gap to life-saving drugs could be reduced by the UNITAID initiative to pool patents for the many different ARVs, but the reality is that UNITAID is still a promise. To surmount this global problem of inequity requires a rethinking of traditional models of drug access and health objectives that should not be compromised by commercial interests.

Article Information

Identifiers and Pagination:

Year: 2010
Volume: 4
First Page: 25
Last Page: 27
Publisher Id: TOAIDJ-4-25
DOI: 10.2174/1874613601004020004

Article History:

Received Date: 15/6/2009
Revision Received Date: 16/6/2009
Acceptance Date: 1/7/2009
Electronic publication date: 19/1/2010
Collection year: 2010

© Zakus et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Faculty of Medicine, University of Toronto, Canada; Tel: +1 416-978-1458; Fax: +1 416-946-7910; E-mail:

Track Your Manuscript:


"Publishing with Bentham Open was a great experience. The timeliness and communication were outstanding. I am hopeful that I will have the opportunity to publish with Bentham Open again in the future."

Dr. Daniel B. Chastain
Pharm.D., AAHIVP, Clinical Pharmacy Specialist, Infectious Diseases, Phoebe Health, USA

SCImago Journal Ranking

SCImago Journal & Country Rank

Browse Contents

Webmaster Contact:
Copyright © 2021 Bentham Open